APPLICATION
NDA204803
TYPE
NDA
ORIGINAL APPROVAL
2021-02-01
LATEST ACTION
2022-08-03
ROUTE
INFILTRATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
POSIMIR · ReferenceDiscontinued
BUPIVACAINE 660MG/5ML (132MG/ML) · SOLUTION · INFILTRATION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.